Search Results
What Major Themes Define Recent Lower-Risk MDS Prognostication, Treatment?
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
Low-risk MDS & the 'Repair MDS' Clinical Trial
MDS - Myeloplastic Syndromes - 2023 Best of Hematology Conference
My approach to MDS management
Management of Low Risk MDS with Dr. Mikkael Sekeres
Mutations in MDS - Prognostic and Therapeutic Implications
MDS: Factors to Consider in the Initial Treatment Approach
Management of Lower-risk MDS without Del5q and Refractory to ESAs
What’s on the horizon for higher-risk MDS? An update on emerging novel agents?
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Updates from the 17th International Congress on MDS: Promising Treatment Advances
